INTRODUCTION
============

The *c-jun* oncoprotein is an essential component of an activator protein transcription complex. On hetero-dimerization with other Jun/Fos members it forms an active activator protein -1 complex (AP-1), which regulates the expression of various target genes harboring AP-1--binding DNA elements within their promoters. AP-1 controls the expression of genes that regulate several crucial cellular functions such as cell cycle progression, migration, proliferation, and apoptosis. *c-jun* is activated upon phosphorylation by *c-jun* N-terminal kinase (JNK), which responds to diverse biological stress signals ([@B22]).

*c-jun* functions as both a positive and negative regulator of apoptosis ([@B37]). Nerve growth factor (NGF) withdrawal induced neuronal apoptosis is reduced by *c-jun* inhibition, and mice expressing the *c-jun* phosphorylation site mutant (*c-jun* A63/73) are resistant to kainate seizure-induced apoptosis ([@B15]; [@B5]). In contrast, *c-jun* inhibits TNF-α--induced apoptosis via p53/p21 in transformed fibroblasts ([@B13]), and p53 is induced in *c-jun*^−/−^ liver tumors. p53 however is not activated in *c-jun*^−/−^ hepatocytes ([@B13]), suggesting acute *c-jun* deficiency induces apoptosis eliminating p53-overexpressing cells.

Reactive oxygen species (ROS) are thought to play an important role in cell death: apoptosis, programmed necrosis, cellular proliferation, premature senescence, genomic instability, and cellular invasiveness. On one hand, ROS induced by oncogenic Ras or ErbB2 has been shown to induce antiproliferative signals that block cellular proliferation and growth ([@B11]). ROS can cooperate with oncogenic signals and in some circumstances ROS production is associated with activation of growth receptors including transforming growth factor-β and platelet-derived growth factor (PDGF; [@B34]; [@B3]). The carcinogenic effect of ROS has been linked to increased cellular proliferation rate seen in many cancer cell lines ([@B14]; [@B9]). Mitochondria are the major source of cellular ROS, derived from leakage of electrons from carriers in the electron transport chain ([@B35]) produced during the turnover of complex I and complex II. Molecular oxygen is converted to superoxide (O~2~^−^), which in turn develops into ROS. Nonmitochondrial ROS are derived from other compartments including peroxisomes, plasma membrane, the endoplasmic reticulum, Golgi complex, lysosomes, and the nucleus. ROS may be generated by reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, which includes a catalytic subunit of the NADPH oxidase (NOX) family ([@B23]). ROS formation and efflux may be altered by the mitochondrial inner transmembrane potential (Δ^ψ~m~^), pH gradient and the outer mitochondrial membrane potential, O~2~^−^ production is enhanced by high Δ^ψ~m~^ ROS leave the mitochondria either via diffusion or via active carriers such as the inner membrane anion channel (IMAC) or the voltage-dependent anion channel (VDAC; [@B7]).

Superoxide dismutases are the antioxidant enzymes that catalyze the dismutation of O~2~ to H~2~O~2~. There are two forms of intracellular superoxide dismutases (SODs) in mammalian cells: nuclear and cytoplasmic CuZnSOD (SOD-1) and mitochondrial matrix localized MnSOD (SOD-2).

In addition to passive or active diffusion from mitochondria, ROS undergo enzymatic elimination via MnSOD ([@B26]) or CuZnSOD ([@B30]). Further detoxification is undertaken by glutathione peroxidase (GPX; [@B29]) which uses reduced glutathione (GSH) and/or catalase in which converts H~2~O~2~ to H~2~O ([@B32]).

The *c-jun* gene plays a central role in the diverse functions of the AP-1 complex. Although the number of studies is small, analysis of acute loss of target genes have revealed distinct results compared with germ line deletion studies ([@B33]). The current studies were conducted first, therefore, to determine the signaling pathways regulated by endogenous *c-jun* in vivo. To this end, *c-jun^fl/fl^* mice were deployed, and excision was conducted using cre recombinase. Laser capture microdissection (LCM) was conducted of cells deleted of *c-jun*, and genome-wide expression analysis was conducted to determine signaling pathways regulated by *c-jun* in vivo. Second, *JNK* and the *c-jun* genes have been linked to both the inhibition and induction of cellular apoptosis ([@B46]; [@B21]; [@B45]). The current studies were therefore conducted to examine the effect of acute *c-jun* excision on cellular survival.

MATERIALS AND METHODS
=====================

Transgenic Mice and Expression Plasmids
---------------------------------------

Transgenic animals carrying floxed c*-jun* alleles, c*-jun^f/f^*, and mouse mammary tumor virus (MMTV)-Cre were previously described ([@B47]). The mammary gland mRNA was obtained from virgin female mice at 2 mo of age. All experimental procedures conducted on these mice were approved by the ethics committee of Thomas Jefferson University. Quantitation of mammary epithelial cell number was conducted as described ([@B2]). Apoptosis in situ was determined using the TdT in situ apoptosis kit (DAB TUNEL-based Apoptosis Detection Assay; R&D Systems, Minneapolis, MN). The murine embryonic fibroblasts (MEFs) were produced as previously described ([@B1]) and cultured following the 3T3 protocol. The expression plasmids for adenovirus Cre (Ad-Cre) or control (Ad-Null) were previously described ([@B44]). The rat *c-jun* was subcloned in murine sarcoma cytomegalovirus (MSCV)-internal ribosome entry site (IRES)-green fluorescent protein (GFP) to form MSCV-*c-jun*-IRES-GFP.

Reagents and Antibodies
-----------------------

The following reagents and antibodies were used: H~2~DCFDA (Invitrogen, Carlsbad, CA); anti-Cre (EMD Biosciences, San Diego, CA); anti-*c-jun* (H-79), anti-survivin, and anti-rho-guanine nucleotide dissociation inhibitor (GDI; Santa Cruz Biotechnology, Santa Cruz, CA); VDAC-1 (Abcam, Cambridge, MA); and DAPI (4′,6′-diamino-2-phenylindole; Sigma-Aldrich, St. Louis, MO). Amplex Red H~2~O~2~ detection kit was from Invitrogen. Reagents and their final concentration used in experiments were *N*-acetyl-[l]{.smallcaps}-cysteine (NAC; 5 mM), diphenyleneiodonium chloride (DPI; 10 μM), ammonium pyrrolidinedithiocarbamate (PDTC; 10 μM), rotenone (1 μg/ml), and H~2~O~2~ were purchased from Sigma-Aldrich. Measurements of H~2~O~2~ production were conducted using Amplex Red Hydrogen Peroxide/Peroxidase Assay Kit from Invitrogen ([@B27]). Catalase activity was determined using the Catalase Assay Kit from Caymen Chemicals (Ann Arbor, MI; [@B38]), and the In Gel MnSOD activity was done as previously described ([@B4]).

Cell Culture, Viral Cell Transduction, and Reporter Gene Assays
---------------------------------------------------------------

Cells were maintained under standard tissue culture conditions in DMEM supplemented with 10% FBS and 100 mg/ml each of penicillin-streptomycin at 37°C with 5% CO~2~. Adenovirus propagation was previously described ([@B43]). Infection was done at a multiplicity of infection (MOI) of 50, cells were cultured overnight, and media were changed before experimental analysis. Retroviral infections were conducted as previously described ([@B43]). Transfections were conducted using Genejuice transfection reagent (EMD Biosciences, San Diego, CA) as described ([@B6]). Statistical analysis was conducted using the Mann-Whitney U test.

Immunofluorescence and Confocal and Electron Microscopy
-------------------------------------------------------

*c-jun^f/f^* cells were grown on chamber slides and then treated with either Ad-Null or Ad-Cre. Cells were then stained with antibodies against cre-recombinase and *c-jun*, and DAPI was used as nuclear stain. The microscopic images were captured using the 20× and 63× objectives of an Olympus LSM-5 Meta laser confocal scanning microscope (Olympus America, Center Valley, PA). Briefly, confluent *c-jun^f/f^* cells treated with adenoviruses were harvested and washed with PBS. Cells were fixed in paraformaldehyde and permeabilized with Triton X-100, followed by a PBS wash, and were stained with primary antibodies and consequently with fluorophore-tagged secondary antibodies.

For electron microscopy (EM) virus-treated cells were plated on fibronectin-coated glass coverslips and grown to approximately 80% confluence. The cells were then rinsed with PBS and fixed in 2.5% glutaraldehyde/0.1 M for 2 hr at room temperature, postfixed in 1% osmium tetroxide for 1 hr, en bloc stained with uranyl acetate, and processed in situ for conventional electron microscopy araldite embedding procedure. Layers of plastic-embedded cells were removed from the coverslips, re-embedded in plastic, and ultrathin sections were cut parallel to the original plane of the coverslip. Sections were then poststained with uranyl acetate and lead citrate, and observed and photographed with a Hitachi H-7600 transmission electron microscope (Hitachi, Tokyo, Japan).

Assessment of ROS Production
----------------------------

H~2~DCFDA staining for ROS was performed on fibroblasts treated with Ad-Null and Ad-Cre according to the manufacturer\'s instructions. DCFDA, at 5 mM, was used for staining the cells for 30 min, followed by fluorescence-activated cell sorting (FACS) sorting of stained cells at excitation and emission wavelengths of 492--495 and 517--527 nm, respectively. H~2~DCFDA is a cell-permeant indicator for ROS that is nonfluorescent until the acetate groups are removed by intracellular esterases and oxidation occurs within the cell.

Assays for Assessment of Cellular Apoptosis
-------------------------------------------

FACS-based cell cycle assays were performed using propidium iodide staining of the virus-treated cells in citrate buffer. Assays of cellular apoptosis were performed using annexin V staining on living cells using the annexin V kit from BD Biosciences (San Jose, CA) followed by the FACS sorting of fluorescent apoptotic cells.

Real-Time PCR and ELISA
-----------------------

All gel-based and real-time quantitative RT-PCR (qRT-PCR) assays were performed as previously described ([@B20]). Briefly, RNA extracted using standard GITC method was RQ1 DNase I (Promega, Madison, WI) treated, phenol-chloroform extracted, and quantitated using a Nanodrop spectrophotometer (Nanodrop Tech, Wilmington, DE). An equal quantity of RNA from each sample was reverse-transcribed using Iscript Reverse transcriptase (Bio-Rad, Hercules, CA). Primers for all the genes and gene transcripts including housekeeping control genes and gene transcripts are listed in [Table 1](#T1){ref-type="table"}.

###### 

List of oligonucleotide primers used in PCR, RT-PCR, real-time qRT-PCR analysis, and chromatin immunoprecipitation assays

  Gene                                                                  Orientation   Sequence 5′→3′
  --------------------------------------------------------------------- ------------- -------------------------------------
  *c-jun* genotyping                                                    Forward       CTC ATA CCA GTT CGC ACA GGC GGC
                                                                        Reverse       CCG CTA GCA CTC ACG TTG GTA GGC
                                                                        Reverse       CAG GGC GTT GTG TCA CTG AGC T
  RPL-19 (DNA PCR)                                                      Forward       AAT GCT CGG ATG CCT GAG AA
                                                                        Reverse       CTC CAT GAG GAT GCG CTT GT
  Cre recombinase                                                       Forward       TGC TCT GTC CGT TTG CCG
                                                                        Reverse       ATC GTG TCC AGA CCA GGC
  RPL-19 (for RT-PCR)                                                   Forward       CTG AAG GTC AAA GGG AAT GTG
                                                                        Reverse       GGA CAG AGT CTT GAT GAT CTC
  *c-jun* (for RT-PCR)                                                  Forward       AGA GCG GTG CCT ACG GCT ACA GTA A
                                                                        Reverse       CGA CGT GAG AAG GTC CGA GTT CTT G
  MnSOD                                                                 Forward       GCA CAT TAA CGC GCA GAT CA
                                                                        Reverse       AGC CTC CAG CAA CTC TCC TT
  CuZnSOD                                                               Forward       AAG GCC GTG TGC GTG CTG AA
                                                                        Reverse       CAG GTC TCC AAC ATG CCT CT
  GPX                                                                   Forward       CCT CAA GTA CGT CCG ACC TG
                                                                        Reverse       CAA TGT CGT TGC GGC ACA CC
  Catalase                                                              Forward       GCA GAT ACC TGT GAA CTG TC
                                                                        Reverse       GTA GAA TGT CCG CAC CTG AG
  Rac 1                                                                 Forward       CTG CCT GCT CAT CAG TTA CACG
                                                                        Reverse       GGA CAG AGA ACC GCT CGG ATA
  Rac 2                                                                 Forward       CAG GTC AGG AGG ACT ATG ACC G
                                                                        Reverse       GAT TGC CTC ATC GAA GAC GGT
  p40phox                                                               Forward       CAA AGT CTA CAT GGG CGC AAA
                                                                        Reverse       TGT CTT CAT AGA AGT AGC ATC GTA GCC
  p67phox                                                               Forward       CTA TCT GGG CAA GGC TAC GGT T
                                                                        Reverse       CAC AAA GCC AAA CAA TAC GCG
  gp91phox                                                              Forward       AGT CGG GAT TTC TGA CCG GTA T
                                                                        Reverse       TCC AGT CTC CAA CAA TAC GGA TAT G
  18S r-RNA                                                             Forward       AGG AAT TCC CAG TAA GTG CG
                                                                        Reverse       GCC TCA CTA AAC CAT CCA A
  AP-1 elements                                                         Forward       AGA AGT GAG TGG ATG TGA TGC CCA
                                                                        Reverse       AGT ACA TCG TTG ACT GCA CGA CCT
  Negative (4)                                                          Forward       TTC ATT TGC TGT CTG TCA CCG GG
                                                                        Reverse       TGC AGA TAG TCC CAG CAT TGG GTA
  Oligos used for creating AP-1 deletion in MnSOD promoter constructs   Forward       CAG GGC ATA AAT TAA GAA GGC CCC TG
                                                                        Reverse       CAG GGG CCT TCT TAA TTT ATG CCC TG

Laser Capture Microdissection
-----------------------------

Mammary glands from the following bitransgenic mice genotypes: wild-type (cre^+^/*c-jun^wt/wt^*; resulting genotype: *c-jun*^+/+^), heterozygotes (cre^+^/*c-jun^f/w^*; resulting genotype: *c-jun*^+/−^), or knockouts (cre^+^/*c-jun^f/f^*; resulting genotype: *c-jun*^−/−^) were frozen in optimal temperature compound on dry ice. The frozen tissue blocks were trimmed and cryosectioned at −20°C in a cryostat machine onto cold, RNase-free sterile glass slides. Each slide was mounted in the LCM machine, and ∼200--1000 mammary epithelial cells were picked by firing lasers on to the resin-bearing caps. RNA was isolated using microRNAeasy RNA extraction kits (Qiagen, Valencia, CA) followed by DNase treatment and concentrated in a small volume using DNA-free kit (Zymo Research, Orange, CA). RNA quantity and quality was measured in a Nanodrop 1000 spectrophotometer. This RNA was then subjected to hybridization to Affymetrix RNA chips (Santa Clara, CA) for assessing the relative expression of genes affected by *c-jun* excision.

Gene Expression Arrays and Pathways Analysis
--------------------------------------------

RNA samples extracted from laser capture microdissected mammary epithelial cells from wild-type *c-jun*^+/+^ and knockout *c-jun*^−/−^ bitransgenic mice mammary glands were processed for Affymetrix 430 2.0 arrays to determine gene expression. RNA quality was determined by gel electrophoresis. Probe synthesis and hybridization were performed as previously described ([@B24]). Analysis of the arrays was performed using the R statistics package ([www.r-project.org](http://www.r-project.org)) and the limma library of the Bioconductor software package ([www.bioconductor.org](http://www.bioconductor.org)). Arrays were normalized using robust multiarray analysis, and a p of 0.05 was applied as statistical criterion for differentially expressed genes ([@B48]). These genes were then grouped using hierarchical clustering with "complete" agglomeration. Expression profiles are displayed using Treeview (<http://taxonomy.zoology.gla.ac.uk/ROD/treeview.html>). Classification and clustering for pathway level analysis used ASSESS (Analysis of Sample Set Enrichment Scores) ([@B12]).

RNA amplification was performed from 5 ng of total RNA followed by cDNA production and its purification using a DNA cleaning kit from Zymo Research. The purified cDNA was then quantified on a Nanodrop ND-1000 Spectrophotometer (Thermo Scientific, Waltham, MA) and 5 μg of amplified cDNA was fragmented and chemically labeled with biotin to generate biotinylated cDNA using FL-Ovation cDNA biotin labeling module V2 (NuGen Technologies, San Carlos, CA).

Low-Density Apoptosis Arrays
----------------------------

The cDNA prepared from purified RNA extracted *c-jun^f/f^* fibroblasts treated with either adenovirus null (wild type \[WT\]) or adenovirus expressing cre-recombinase (knockout \[KO\]) was amplified on prefabricated, low-density, 384-well apoptosis arrays and run according to the manufacturer\'s instructions (SA Bioscience, Gaithersburg, MD).

RESULTS
=======

Endogenous *c-jun* Inhibits Signaling Pathways Promoting Apoptosis In Vivo
--------------------------------------------------------------------------

*c-jun* has been shown to either inhibit or induce cellular apoptosis in different cell types ([@B36]; [@B41]; [@B42]; [@B17]; [@B31]). We conducted studies to determine the role of endogenous *c-jun* in mammary epithelial cell survival. Because *c-jun* somatic deletion is embryonically lethal, we intercrossed floxed *c-jun* (*c-jun^f/f^*) transgenic mice with MMTV-Cre mice and conducted LCM of mammary epithelial cells from mouse mammary glands (*Materials and Methods*; [Figure 1](#F1){ref-type="fig"}A). mRNA derived from mammary epithelial cells of six separate transgenic mice was subjected to microarray analysis and subsequently to pathways analysis using ASSESS ([Figure 1](#F1){ref-type="fig"}A). Gene expression pathways and the induction of apoptosis associated with ROS production were induced upon *c-jun* deletion ([Figure 1](#F1){ref-type="fig"}A). To examine whether *c-jun* deletion--regulated expression of specific pro- or antiapoptotic genes, we conducted RT-PCR--based expression analysis of 87 genes (using low-density apoptosis arrays) previously shown to be involved in apoptosis. Thirty-nine proapoptotic genes were induced, and 16 anti-apoptotic genes were repressed upon deletion of *c-jun* ([Figure 1](#F1){ref-type="fig"}B). The relative change in gene expression of the antiapoptotic and proapoptotic genes are shown on a log scale ([Figure 1](#F1){ref-type="fig"}C). Deletion of *c-jun* induced expression of apoptotic genes and reduced expression of antiapoptotic genes ([Figure 1](#F1){ref-type="fig"}C). The inhibitor of apoptosis protein (IAP) BIRC5 (survivin) was repressed substantially upon deletion of endogenous *c-jun* ([Figure 1](#F1){ref-type="fig"}C). RT-PCR--based analysis of *c-jun* gene expression within laser capture--microdissected mammary epithelial cells derived from Cre recombinase expressing bitransgenic mammary glands also showed reduction in *c-jun* expression ([Figures 1](#F1){ref-type="fig"}D).

###### 

Endogenous *c-jun* represses gene expression pathways governing cellular apoptosis and ROS production in vivo. (A) Schematic representation of intercrosses between MMTV-Cre and *c-jun^f/f^* transgenic mice performed to produce *c-jun*^+/+^ and *c-jun*^−/−^ mice. The mammary glands from these mice were subjected to laser capture microdissection (LCM) to enrich and purify mammary epithelial cells for performing microarray-based gene expression analysis. ASSESS pathway analysis was performed on the differentially expressed genes. The blue gradient coloration in the heat map shows down-regulation of the indicated pathways, whereas red depicts up-regulation of those pathways. (B) Heat map of differentially expressed pro- and antiapoptotic gene transcripts up- or down-regulated upon treatment of floxed *c-jun* cells with Ad-Null or Ad-Cre. (C) Scatter plot for the gene expression profiling performed using low-density apoptosis qRT-PCR arrays indicating expression of pro- and antiapoptosis genes, with the direction of gene expression show by red (up-regulated) and green (down-regulated) genes.
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To determine whether the excision of *c-jun* within the mammary epithelial cells had affected mammary gland development and mammary ductal morphology, we performed mammary gland whole-mount analyses. Mammary glands squashes prepared by staining the entire \#4 mammary glands from cre^+^/c-jun^f/f^ (resulting genotype: *c-jun*^−/−^ or KO) and cre^+^c-jun^f/w^ (resulting genotype: *c-jun*^+/−^) to littermate controls cre^+^/c-jun^wt/wt^ (resulting genotype: *c-jun*^+/+^ or WT) were photographed and carefully compared (Supplemental Figure 1A). The morphological structure and architecture was unchanged between genotypes. Mammary gland ductal branching complexity number was also largely unaltered (Supplemental Figure 1A). Studies of the cellular components of the mammary gland of the mice were next conducted. The relative number of cells per field and the area covered by cells lining mammary glands were carefully assessed and characterized by pixels per field and demonstrated ∼50% reduction in the number of epithelial cells observed per field and the same for their area. (Supplemental Figure 1B).

Endogenous *c-jun* Inhibits ROS Production via Mitochondrial Complex I and NOX1
-------------------------------------------------------------------------------

To determine the role of endogenous *c-jun* in ROS production, *c-jun^fl/fl^* MEFs ([Figure 2](#F2){ref-type="fig"}A) were transduced with an adenoviral expression vectors encoding cre (Ad-Cre) or a control vector (Ad-Null). The excision of *c-jun* was documented by RT-PCR analyses for *c-jun* mRNA normalized to the internal control Rpl-19 and deletion of the floxed site by PCR ([Figure 2](#F2){ref-type="fig"}AIII). ROS production was visualized by 2′7′-dichlorofluorescein diacetate (DCFDA) and quantitated by FACS sorting ([Figure 2](#F2){ref-type="fig"}, B and C), which demonstrated an approximate doubling of DCFDA positivity ([Figure 2](#F2){ref-type="fig"}B). Confocal microscopy combining staining of mitochondria with mitotracker dye evidenced a colocalization of DCFDA with mitochondria (yellow; [Figure 1](#F1){ref-type="fig"}C). Additional nonmitochondrial DCFDA was also seen. Reintroduction of *c-jun* by retroviral transduction into *c-jun*^−/−^ cells reversed the increase in DCFDA positivity by FACS (data not shown). To examine further the source of endogenous ROS repressed by *c-jun*, ROS inhibitors were used. NAC and PDTC had been thought to act as antioxidants. PDTC inhibits IκB-ubiquitin ligase activity ([@B16]). Rotenone, is an inhibitor of the mitochondrial electron transport chain, and DPI is an inhibitor of the NOX enzymes that are the major mediators of nonmitochondrial ROS ([@B18]). Addition of DPI, PDTC, or rotenone reduced DCFDA fluorescence ([Figure 2](#F2){ref-type="fig"}D) suggesting both NOX- and mitochondrial-dependent sources of ROS in *c-jun*^−/−^ cells.

###### 

Somatic excision of *c-jun* induces mitochondrial and NOX1-dependent ROS production. (AI) Schematic diagram of the genomic wild-type (*c-jun*), floxed (*c-jun^f/f^*), and deleted *c-jun* (*c-junP*^Δ^) locus with loxP sites (◀) and PCR primer binding sites (→). Adenovirus treatments to floxed *c-jun* cells, and resulting cellular genotypes. (II) Confocal microscopic images of Ad-Cre--treated *c-jun^f/f^* fibroblasts showing expression of Cre-recombinase and *c-jun*. DAPI-stained nuclei. Note that the cells expressing Cre have lost *c-jun* expression. (III) RT-PCR showing expression of cre-recombinase, *c-jun*, and *rpl-19* (housekeeping gene control) mRNA transcripts in RNA from no virus NS Ad-Null-- and Ad-Cre--treated *c-jun^f/f^* fibroblasts. PCR genotyping of DNA from no virus and Ad-Null-- and Ad-Cre--treated *c-jun^f/f^* cells showing floxed and excised *c-jun* alleles. (B) FACS-based quantification of DCFDA-stained ROS production in Ad-Null-- and Ad-Cre--treated floxed *c-jun* cells (data are mean ± SEM). (C) High-resolution confocal microscopic images of the DCFDA staining of intracellular ROS in Ad-Cre--treated floxed *c-jun* cells. Mitotracker mitochondrial stain was used for visualization of mitochondria (data are mean ± SEM). (D) DCFDA staining of Ad-Null-- or Ad-Cre--treated fibroblasts after addition of various ROS inhibitors.
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Endogenous *c-jun* Maintains Mitochondrial Membrane Potential
-------------------------------------------------------------

Apoptosis assessed by annexin V staining was increased fourfold in *c-jun*^−/−^ cells ([Figure 3](#F3){ref-type="fig"}A). EM of the mitochondria demonstrated mitochondrial blebbing ([Figure 3](#F3){ref-type="fig"}B) characteristic of apoptotic cell death. The size of mitochondria assessed by mitotracker staining was unchanged in *c-jun*^−/−^cells ([Figure 3](#F3){ref-type="fig"}C). The mitochondrial membrane potential (Dym) regulates ROS formation and efflux. O~2~^−^ production increased the number of cells with medium and low Dym. Quantitation of JC-1 staining was conducted to measure Dym and demonstrated a 3--5-fold increase in staining in *c-jun*^−/−^ cells ([Figure 3](#F3){ref-type="fig"}D).

![c-*jun* determines mitochondrial membrane potential and apoptosis. (A) Annexin V staining for assessment of apoptotic cells after *c-jun* excision (data are mean ± SEM for n \> 5). (B) Electron micrographs of the floxed *c-jun* cells with (No virus or Ad-Null) or without *c-jun* expression (Ad-Cre). (C) Mitochondrial membrane potential measurements using JC-1 mitochondrial probe after *c-jun* excision (data are mean ± SEM). (D) Quantitation of JC-1 staining and measurement of Dym, indicating a 3--5-fold increase in staining in *c-jun*^−/−^ cells.](zmk0231096900003){#F3}

To determine the role of c-Jun and c-Jun--regulated ROS in cellular growth and apoptosis, cellular proliferation assays were conducted. *c-jun*^−/−^ MEFs have a severe proliferative defect that can be passaged only a few times before entering premature senescence. To avoid any independent effects of serial passage and senescence, the studies were conducted acutely on early-passage MEFs. *c-jun^f/f^* cells were transduced with an adenovirus expressing cre via an IRES to the GFP protein (Supplemental Figure 3A). Immunohistochemical staining confirmed cells transduced with Cre lacked c-Jun protein. GFP-positive cells were selected and analyzed. *c-jun*^−/−^ MEFs demonstrated a reduced proliferation rate assessed by cellular counting (Supplemental Figure 3A) or by MTT assays (Supplemental Figure 3B). *c-jun*^−/−^ MEFs displayed enhanced sensitivity to H~2~O~2~-induced apoptosis (Supplemental Figure 3C).

*c-jun*--dependent ROS Production Governs MnSOD, Catalase, and GPX Expression
-----------------------------------------------------------------------------

We examined further the mechanisms governing endogenous *c-jun*--mediated inhibition of ROS production. Increased ROS production in the *c-jun*^−/−^ cells may be a consequence of either reduced ROS elimination or increased ROS production. O~2~^−^ is converted to H~2~O~2~ by matrix manganese superoxide dismutase (MnSOD; [@B40]), whereas catalase and GPX either separately or synergistically convert H~2~O~2~ to H~2~O~.~ To determine the mechanism by which *c-jun* inhibited ROS production, we examined the role of *c-jun* in regulating MnSOD and catalase abundance. We examined the abundance of MnSOD by quantitative real-time RT-PCR upon acute excision of *c-jun* using Ad-Cre. As endogenous *c-jun* mRNA levels decreased ([Figure 4](#F4){ref-type="fig"}AI), MnSOD mRNA transcript abundance increased ([Figure 4](#F4){ref-type="fig"}AII). O~2~^−^ released to the mitochondrial intramembrane space is dismutated by CuZnSOD ([@B30]). ROS are further detoxified by GPX ([@B29]), which uses GSH in catalysis. The relative abundance of MnSOD, CuZnSOD, catalase, and GPX were assessed upon acute deletion of *c-jun* to determine the role of endogenous *c-jun* in regulating the key components involved in eliminating ROS ([Figure 4](#F4){ref-type="fig"}A, III--V). Quantitative RT-PCR transcript analysis was conducted, and mean data of multiplicate studies demonstrated that *c-jun* excision induced MnSOD 2.5-fold. More modest changes occurred with catalase and GPX (1.5- to 2-fold). CuZnSOD mRNA expression was unchanged ([Figure 4](#F4){ref-type="fig"}A, III--V). The finding that MnSOD mRNA increased and CuZnSOD was unchanged upon excision of *c-jun* in fibroblasts was confirmed by microarray analysis of the *c-jun*^−/−^ mammary gland in which MnSOD was increased (1.6-fold, mean of n = 3), and CuZnSOD mRNA abundance was unchanged.

![c-*jun* excision induces MnSOD expression via a ROS-dependent mechanism. (A) qRT-PCR--based assessment of expression of *c-jun* (I), MnSOD (II), CuZnSOD (III), catalase (IV), and GPX (V) transcripts at various time points after treatment of floxed *c-jun* cells with Ad-Null or Ad-cre to excise the *c-jun* gene. The real-time qRT-PCR expression data for various targets were normalized to amplification of 18S rRNA housekeeping gene control in every sample. (B) Expression of *c-jun* and MnSOD transcripts after treatment of Ad-Null-- or Ad-Cre--treated floxed *c-jun* cells with the ROS inhibitor DPI. (C) Quantitation of H~2~O~2~ levels after *c-jun* excision and DPI treatment. (D) Catalase enzyme activities and (E) MnSOD enzyme activity in Ad-Null-- or Ad-Cre--treated floxed *c-jun* cells in the presence of various ROS inhibitors (data are mean ± SEM).](zmk0231096900004){#F4}

We had previously shown that ROS induces MnSOD expression ([@B39]). We therefore examined whether inhibition of ROS production in *c-jun*^−/−^ cells was responsible for the increase in MnSOD. The addition of DPI ([Figure 4](#F4){ref-type="fig"}B), rotenone, or PDTC (not shown) reversed the hyperactivation of MnSOD. Thus, increased ROS from NOX1 and mitochondrial sites produced in *c-jun*^−/−^ cells enhances MnSOD expression. Consistent with an important role for MnSOD in converting O~2~ to H~2~O~2,~ H~2~O~2~ production ([Figure 4](#F4){ref-type="fig"}C) was reduced by DPI. Consistent with the induction of expression in *c-jun*^−/−^ cells, MnSOD enzyme activity was also increased in *c-jun*^−/−^ cells ([Figure 4](#F4){ref-type="fig"}D). The induction of MnSOD activity in *c-jun*^−/−^ cells was reduced by DPI ([Figure 4](#F4){ref-type="fig"}D). To determine whether the increase in H~2~O~2~ abundance in *c-jun*^−/−^cells was due to reduced catalase activity, catalase activity assays were conducted. Catalase activity was reduced by 60% upon deletion of *c-jun* ([Figure 4](#F4){ref-type="fig"}D). The reduction in catalase activity was partially reversed by DPI, suggesting NOX-dependent ROS are a source of reduced catalase activity in *c-jun*^−/−^ cells.

Endogenous *c-jun* Induces Survivin (BIRC5) in Part via ROS
-----------------------------------------------------------

Microarray and RT-PCR analysis of mRNA from LCM of the mammary epithelial cell targeted MMTV-Cre/*c-jun^fl/fl^* bitransgenics demonstrated a reduction in the abundance of several antiapoptotic genes ([Figure 1](#F1){ref-type="fig"}, B and C). The abundance of BIRC5 (survivin), in particular, was down-regulated. To determine whether BIRC5 was also a direct target of endogenous *c-jun*, acute excision of *c-jun* was conducted and BIRC5 abundance was determined ([Figure 5](#F5){ref-type="fig"}A). *c-jun* excision was associated with a decrease in BIRC5 (survivin) mRNA (by RT-PCR) and protein levels. Survivin abundance in *c-jun*^−/−^ cells was reduced in part by the addition of ROS inhibitors ([Figure 5](#F5){ref-type="fig"}B). DPI and PDTC treatment increased survivin abundance in *c-jun*^−/−^ cells 3--5-fold ([Figure 5](#F5){ref-type="fig"}B, lanes 5 vs. 7 and 8). Reintroduction of *c-jun* restored *c-jun* and survivin levels and reversed aberrant ROS production ([Figure 5](#F5){ref-type="fig"}C).

![Endogenous *c-jun* maintains survivin abundance. (A) mRNA and protein abundance for *c-jun* and survivin determined after acute excision of *c-jun* using Ad-Cre treatment of *c-jun^fl/fl^* cells quantitated by RT-PCR (data are mean ± SEM for n \> 5). (B) Western blot analysis of surviving abundance in wild-type versus *c-jun*^−/−^ cells after treatment with ROS inhibitors for 24 h as indicated. (C) Western blot and DCFDA analysis of *c-jun*^−/−^ cells transduced with retrovirus encoding *c-jun. c-jun* restores endogenous *c-jun* levels and reverses the increased production of ROS.](zmk0231096900005){#F5}

Collectively these studies demonstrate acute *c-jun* excision increased proapoptosis and inhibited antiapoptotic gene expression in vivo. The mammary epithelium in vivo *c-jun* excision or *c-jun^fl/fl^* cultured cells induced expression of genes that catalase ROS, mitochondrial membrane potential and both mitochondrial and NOX-based ROS, which induced MnSOD, and catalase expression. The inhibition of ROS production by endogenous *c-jun* reduced cellular apoptosis and promoted contact-independent growth. Because *c-jun* functions as a pivotal downstream regulator of diverse biological processes governing cellular proliferation and growth, these studies provide a direct link between *c-jun* and mitochondrial function.

DISCUSSION
==========

The current studies demonstrate an essential role for endogenous *c-jun* in maintaining mammary epithelial cellular survival in vivo. Double transgenic mice (*c-jun^fl/fl^*-MMTV-Cre) and conditional knockout MEFs were generated to identify the key signaling pathways regulated by endogenous *c-jun* in vivo. Genome-wide expression studies conducted of mRNA derived from laser capture--microdissected mammary epithelium from these double transgenic mice identified the key pathways regulated by endogenous *c-jun*. In the mammary epithelium and fibroblasts the key pathways regulated by endogenous *c-jun* govern cellular apoptosis and ROS production. RT-PCR analysis of 87 genes confirmed that 39 apoptotic genes were induced and 16 antiapoptotic genes were repressed upon deletion of *c-jun*.

Herein, acute *c-jun* excision increased apoptosis. The induction of cellular senescence, which occurs upon several cellular divisions, is associated with the induction of p53/p21^CIP1^ ([@B25]). To distinguish the effects of *c-jun* excision from the effects of cellular senescence the molecular events, accompanying acute somatic excision of *c-jun* were characterized. The apoptosis induced upon acute excision of *c-jun* herein was associated with increased annexin V staining, characteristic of phosphatidyl-serine exposure on the cellular membrane seen in apoptosis and features of caspase 3 cleavage and activation (Supplemental Data) indicative of the intrinsic mitochondrial pathways of apoptosis. Mitochondrial morphology reflected the characteristic feature of mitochondrial cristae swelling and inner mitochondrial membrane swelling.

The current studies define a central role for endogenous *c-jun* gene in maintaining ROS homeostasis. The decreased membrane potential of *c-jun*^−/−^ cells would be anticipated to increase ROS production and enhance efflux (Tirosh *et al.*, 2003). Acute *c-jun* excision enhanced ROS production and expression of the enzymes that catalase and detoxify ROS (MnSOD and GPX). The induction of gene expression occurred within 16--18 h. The induction of the cellular ROS-catalyzing enzymes was accompanied by a decrease in mitochondrial membrane potential. ROS are known to induce expression of MnSOD ([@B39]). The enhanced production of MnSOD in *c-jun*^−/−^ cells was abolished by addition of DPI, indicating that ROS production from mitochondrial complex I and NOX are inhibited by endogenous *c-jun*. Thus, endogenous *c-jun* inhibits MnSOD production via NOX1 and mitochondrial complex 1.

Apoptosis is regulated via extrinsic pathways that are triggered by ligand binding, whereas the intrinsic apoptotic pathways involves mitochondria, which release cytochrome *c* that binds and activates Apaf1 (apoptotic protease activation factor 1). Apaf1 induces assembly of the apoptosome, leading to activation of caspase 9 members of the IAP family including survivin and others (ML-IAP, XIAP, CIAP~1~, CIAP~2~, NIAP, and Apollon). These factors block apoptosis downstream of cytochrome *c* release by interfering with caspase 9 activity and processing and inhibiting the terminal effectors caspase-3 and -7. Increased ROS production has been linked to cellular apoptosis through sustained JNK activation and an additional pathway ([@B19]; [@B8]) that is inhibited by a prosurvival NFκB (nuclear factor κB) pathway ([@B40]). The current studies extend these prior observations by demonstrating that the endogenous *c-jun* functions to inhibit ROS production (Supplemental Figure 3). The IAP BIRC5 (survivin) was reduced upon deletion of *c-jun*. Survivin is a 16.5-kDa protein, with a single baculovirus IAP repeat (BIR). Mitochondrial survivin orchestrates a novel pathway of apoptosis inhibition, which contributes to tumorigenesis ([@B10]). On deletion of *c-jun*, ROS levels rise, and survivin and other apoptotic gene levels fall, inducing apoptosis (Supplemental Figure 3). *c-jun* induced survivin abundance in a ROS-dependent manner. ROS generated independently of *c-jun* and other factors also regulate survivin expression. The survivin gene is regulated by a variety of factors including chronic hypoxia, growth factors, HIF1α (hypoxia-inducible factor), and paracrine factors. The independent role of these factors in ROS signaling to the survivin gene remains to be determined.
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